Literature DB >> 31069760

C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

Hang Li1, Bo Zhang2, Meng Ding3, Shang Lu4, Hui Zhou1, Dajun Sun5, Gang Wu6, Xianfeng Gan6.   

Abstract

BACKGROUND: The aim of our study was to explore how C1QTNF1-AS1 regulated miR-221-3p/SOCS3 axis in human hepatocellular carcinoma (HCC).
METHODS: Differentially expressed lncRNAs and genes were examined via RNA-seq. GO analysis and KEGG pathway enrichment analysis were carried out based on the function of dys-regulated mRNAs. RT-qPCR was employed to detect the relative mRNA expression level of C1QTNF1-AS1, miR-221-3p, SOCS3 and key genes in the JAK/STAT signaling pathway in HCC tissues and cells, and western blot analysis was conducted to detect the relative protein expression levels of SOCS3 and key proteins in the JAK/STAT signaling pathway in HCC tissues and cells. MTT assay, transwell assay and flow cytometry were utilized to assess HCC cell proliferation, invasion, migration and apoptosis. Dual luciferase reporter gene assay was used to verify the targeted relationship between C1QTNF1-AS1 and miR-221-3p, as well as between miR-221-3p and SOCS3. A tumorigenicity assay in nude mice was conducted to investigate the effects of C1QTNF1-AS1 on HCC tumor growth in vivo.
RESULTS: C1QTNF1-AS1 and SOCS3 were down-regulated, while miR-221-3p was up-regulated in HCC tissues and cells. In HepG2 and Huh7 cells, overexpression of C1QTNF1-AS1 or SOCS3, as well as silence of miR-221-3p inhibited HCC cell proliferation, migration, and invasion and promoted HCC cell apoptosis. The results of the dual luciferase reporter gene assay indicated that miR-221-3p could directly target both C1QTNF1-AS1 and SOCS3. In addition, up-regulation of C1QTNF1-AS1 suppressed HCC tumor growth in vivo.
CONCLUSION: Overexpression of C1QTNF1-AS1 down-regulated miR-221-3p and subsequently up-regulated SOCS3, thereby inhibiting HCC cell proliferation, migration and invasion and promoting apoptosis through the JAK/STAT signaling pathway.

Entities:  

Keywords:  C1QTNF1-AS1; Hepatocellular carcinoma; SOCS3; miR-221-3p

Mesh:

Substances:

Year:  2019        PMID: 31069760     DOI: 10.1007/s12072-019-09944-5

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  27 in total

1.  miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.

Authors:  Sheng Tan; Rui Li; Keshuo Ding; Peter E Lobie; Tao Zhu
Journal:  FEBS Lett       Date:  2011-06-07       Impact factor: 4.124

2.  Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.

Authors:  Luca Quagliata; Matthias S Matter; Salvatore Piscuoglio; Leila Arabi; Christian Ruiz; Alfredo Procino; Michal Kovac; Francesca Moretti; Zuzanna Makowska; Tujana Boldanova; Jesper B Andersen; Monika Hämmerle; Luigi Tornillo; Markus H Heim; Sven Diederichs; Clemente Cillo; Luigi M Terracciano
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

3.  Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.

Authors:  Yasuharu Niwa; Hiroaki Kanda; Yuko Shikauchi; Akio Saiura; Kenichi Matsubara; Tomoyuki Kitagawa; Junji Yamamoto; Takahiko Kubo; Hirohide Yoshikawa
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

4.  Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11.

Authors:  Nigel J Stevenson; Cheryl McFarlane; Seow Theng Ong; Krystyna Nahlik; Alyson Kelvin; Mark R Addley; Aideen Long; David R Greaves; Cliona O'Farrelly; James A Johnston
Journal:  FEBS Lett       Date:  2010-10-08       Impact factor: 4.124

5.  SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.

Authors:  S J Cohney; D Sanden; N A Cacalano; A Yoshimura; A Mui; T S Migone; J A Johnston
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

6.  MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma.

Authors:  Liang Zhou; Zhao-Xu Yang; Wen-Jie Song; Qing-Jun Li; Fan Yang; De-Sheng Wang; Ning Zhang; Ke-Feng Dou
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

7.  Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis.

Authors:  Fu Yang; Xi-song Huo; Sheng-xian Yuan; Ling Zhang; Wei-ping Zhou; Fang Wang; Shu-han Sun
Journal:  Mol Cell       Date:  2013-02-07       Impact factor: 17.970

8.  Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics.

Authors:  Linn Fagerberg; Björn M Hallström; Per Oksvold; Caroline Kampf; Dijana Djureinovic; Jacob Odeberg; Masato Habuka; Simin Tahmasebpoor; Angelika Danielsson; Karolina Edlund; Anna Asplund; Evelina Sjöstedt; Emma Lundberg; Cristina Al-Khalili Szigyarto; Marie Skogs; Jenny Ottosson Takanen; Holger Berling; Hanna Tegel; Jan Mulder; Peter Nilsson; Jochen M Schwenk; Cecilia Lindskog; Frida Danielsson; Adil Mardinoglu; Asa Sivertsson; Kalle von Feilitzen; Mattias Forsberg; Martin Zwahlen; IngMarie Olsson; Sanjay Navani; Mikael Huss; Jens Nielsen; Fredrik Ponten; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2013-12-05       Impact factor: 5.911

9.  Low expression of long noncoding RNA GAS6-AS1 predicts a poor prognosis in patients with NSCLC.

Authors:  Liang Han; Rong Kong; Dan-Dan Yin; Er-Bao Zhang; Tong-Peng Xu; Wei De; Yong-Qian Shu
Journal:  Med Oncol       Date:  2013-08-24       Impact factor: 3.064

10.  miR-19a: an effective regulator of SOCS3 and enhancer of JAK-STAT signalling.

Authors:  Aideen S Collins; Claire E McCoy; Andrew T Lloyd; Cliona O'Farrelly; Nigel J Stevenson
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more
  13 in total

1.  Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Princess D Rodriguez; Lauren Cozzens; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Cancer Res       Date:  2020-06-17       Impact factor: 5.852

2.  C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

Authors:  Jiong Lin
Journal:  Hepatol Int       Date:  2021-02-10       Impact factor: 6.047

3.  Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase.

Authors:  Zushun Chen; Lunan Qi; Hongyuan Fu; Liang Ma
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  mRNA and long non-coding RNA expression profiles of rotator cuff tear patients reveal inflammatory features in long head of biceps tendon.

Authors:  Yi-Ming Ren; Yuan-Hui Duan; Meng-Qiang Tian; Yun-Bo Sun; Tao Yang; Wei-Yu Hou; Chang Liu
Journal:  BMC Med Genomics       Date:  2022-06-20       Impact factor: 3.622

5.  AEG-1/miR-221 Axis Cooperatively Regulates the Progression of Hepatocellular Carcinoma by Targeting PTEN/PI3K/AKT Signaling Pathway.

Authors:  Maheshkumar Kannan; Sridharan Jayamohan; Rajesh Kannan Moorthy; Siva Chander Chabattula; Mathan Ganeshan; Antony Joseph Velanganni Arockiam
Journal:  Int J Mol Sci       Date:  2019-11-06       Impact factor: 5.923

6.  Long Non-Coding RNA C1QTNF1 Antisense RNA 1 Upregulates Hexokinase 2 by Sponging microRNA-484 to Promote the Malignancy of Colorectal Cancer.

Authors:  Shifeng Jin; Yi Liu; Wenjing Wang; Ze Li
Journal:  Cancer Manag Res       Date:  2020-11-24       Impact factor: 3.989

7.  Identification of the Prognostic Value Among Suppressor Of Cytokine Signaling Family Members in Kidney Renal Clear Cell Carcinoma.

Authors:  Changjiu Li; Wenhao Zhang; Tiantian Fang; Ning Li; Yuwei Wang; Lugeng He; Huadong He
Journal:  Front Mol Biosci       Date:  2021-12-02

Review 8.  The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma.

Authors:  Yi Shi; Ji-Bin Liu; Jing Deng; Da-Zhi Zou; Jian-Jun Wu; Ya-Hong Cao; Jie Yin; Yu-Shui Ma; Fu Da; Wen Li
Journal:  Hereditas       Date:  2021-11-10       Impact factor: 3.271

9.  miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.

Authors:  Wei Liu; Qiuping Long; Wei Zhang; Dehui Zeng; Bingbing Hu; Shengyao Liu; Li Chen
Journal:  Aging (Albany NY)       Date:  2021-08-13       Impact factor: 5.682

10.  EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.

Authors:  Ze-Kun Liu; Can Li; Ren-Yu Zhang; Ding Wei; Yu-Kui Shang; Yu-Le Yong; Ling-Min Kong; Nai-Shan Zheng; Ke Liu; Meng Lu; Man Liu; Cai-Xia Hu; Xiao-Zhen Yang; Zhi-Nan Chen; Huijie Bian
Journal:  Mol Cancer       Date:  2021-05-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.